Notice of Annual General Meeting and Annual Report

RNS Number : 1343M

Advanced Medical Solutions Grp PLC

26 April 2018

 

26 April 2018

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Annual Report and Accounts for the year ended

31 December 2017 and Notice of AGM

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, is pleased to announce that in accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2017 were posted to shareholders today and are available on the Investor Relations section of the Company's website http://www.admedsol.com/Investor-Relations.

The notice of meeting convening the Annual General Meeting of the Company, which will be held on 6 June 2018 at 11 a.m. at 85 Gresham Street, London, EC2V 7NQ, was also posted to shareholders today and is available on the Company's website.

- Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Philippa Gardner	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Patrick Robb / Gary Clarence

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal^®, LiquiBand^® and RESORBA^® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

 

END

 

 

MSCIAMATMBJTBLP